Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Non Operating Income (2017 - 2026)

Inspire Medical Systems' Non Operating Income history spans 10 years, with the latest figure at -$226000.0 for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 139.1% to -$226000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$12.5 million, a 320.64% decrease, with the full-year FY2025 number at -$2.7 million, down 210.64% from a year prior.
  • Non Operating Income hit -$226000.0 in Q1 2026 for Inspire Medical Systems, up from -$13.2 million in the prior quarter.
  • Over the last five years, Non Operating Income for INSP hit a ceiling of $5.9 million in Q4 2023 and a floor of -$13.2 million in Q4 2025.
  • Historically, Non Operating Income has averaged $695764.7 across 5 years, with a median of $17000.0 in 2023.
  • Biggest five-year swings in Non Operating Income: skyrocketed 13470.37% in 2022 and later tumbled 1595.5% in 2025.
  • Tracing INSP's Non Operating Income over 5 years: stood at $3.6 million in 2022, then surged by 64.63% to $5.9 million in 2023, then tumbled by 113.09% to -$778000.0 in 2024, then tumbled by 1595.5% to -$13.2 million in 2025, then surged by 98.29% to -$226000.0 in 2026.
  • Business Quant data shows Non Operating Income for INSP at -$226000.0 in Q1 2026, -$13.2 million in Q4 2025, and -$66000.0 in Q3 2025.